Deerfield Management
Illumina, Deerfield Management Partner on Drug Development
The companies plan to use genomics and artificial intelligence to identify therapeutic targets that have a higher probability of success.
Sema4 Raises $121M in Series C Financing Round
BlackRock, the world's largest investment manager, led the round, joined by new investors Deerfield Management and Moore Strategic Ventures as well as existing investors.
Gene Editing Firm Homology Medicines Raises $43.5M in Series A Funding
The new company hopes to turn recombinant adeno-associated virus-based gene editing, which has minimal off-target effects, into new therapies.
PacBio Files for Resale of Shares; Eligible for Proceeds of $14.5M if Warrants are Exercised
NEW YORK (GenomeWeb News) – Pacific Biosciences has filed a prospectus for the resale of up to 5.5 million shares of its stock, issuable upon the exercise of warrants.
Pacific Biosciences Posts Q4, FY2012 Revenue Decline; Expects 2013 Uptick
NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its fourth-quarter revenues fell 52 percent year over year but were up sequentially as product revenue jumped from the third quarter.